 Brochure
download |
| PX’Pharma Added Value |
|
We differentiate from other protein CMOs
by our integrated way of working from early research stage to phases
I & II clinical production. This original approach ensures
seamless transfers and therefore leads to significant reduction
in protein development related budget and duration.
Our programmes are set up to ensure
an optimal transfer to partner CMOs offering large scale facilities
for phase III and market production.
| Development to Production Timeline |
|
Our integrated approach allows to
bring therapeutic protein projects from research grade to clinical
trialsin 6 to 15 months time.
|
|
|
